The list is a first step in negotiations and, given the timing, the details and final pricing will be left to President-elect ...

Few drugs have generated as much excitement as Novo Nordisk's (NYSE: NVO) Ozempic and Wegovy. The U.S. Food and Drug Administration (FDA) approved Ozempic in December 2017 for treating type 2 diabetes ...

A woman who waited for four years on an NHS waiting list for weight-loss support has said she believes she could have avoided developing type 2 diabetes if she was given help sooner. Hannah Baker, 44, ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The most widely known of GLP-1 drugs, semaglutide is sold under well-known brand names such as Ozempic and Wegovy. According to the charity Diabetes UK, it helps the body produce more insulin when ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Ozempic, which the US Food and Drug Administration has approved ... Ozempic is nearly $1,000 for a four-week supply, while Wegovy’s list price is roughly $1,350. While the negotiations process ...

The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs Ozempic and Wegovy ... Friday cheered the new list of selected drugs and urged ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...